Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous MSC therapy in Progressive Supranuclear Palsy
NCT01824121Phase 2Unknown
- Sponsor
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico
- Start
- Dec 2012
- Primary completion
- Dec 2014
- Countries
- 1
01
Overview
A Phase 2 trial of mesenchymal stem cells in progressive supranuclear palsy (PSP), sponsored by Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico. Status: unknown.
02
Drugs
mesenchymal stem cells
03
Conditions
progressive supranuclear palsy (PSP)
Beyond the preview
Go deeper on NCT01824121.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01824121.